4576 — D.Western Therapeutics Institute Balance Sheet
0.000.00%
- ¥5bn
- ¥5bn
- ¥472m
Annual balance sheet for D.Western Therapeutics Institute, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2,308 | 1,934 | 2,335 | 1,867 | 1,126 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 91.9 | 102 | 171 | 117 | 125 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,503 | 2,162 | 2,659 | 2,138 | 1,475 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.29 | 4.57 | 10.1 | 10 | 11.2 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,738 | 2,463 | 2,956 | 2,373 | 1,669 |
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 210 | 193 | 211 | 194 | 133 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 574 | 456 | 1,099 | 1,094 | 936 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,164 | 2,007 | 1,857 | 1,280 | 734 |
Total Liabilities & Shareholders' Equity | 2,738 | 2,463 | 2,956 | 2,373 | 1,669 |
Total Common Shares Outstanding |